Append Medical

Append Medical

Append Medical develops the next generation transcatheter Left Atrial Appendage (LAA) elimination system

Founded 2017 Israel

Israel 22 employees Series A Total: $11.75M Biotechnology, Digital Health +2

Append Medical is an Israeli startup that aims to revolutionize the treatment of non-valvular atrial fibrillation. The company's slogan, "Append Medical develops the next generation transcatheter Left Atrial Appendage (LAA) elimination system," captures the essence of its mission. Its innovative system is designed to prevent blood clot leakage by achieving complete LAA closure, thereby reducing the risk of stroke in patients. What sets Append Medical's solution apart is its unique design, which may mitigate device-related thromboembolism risk by leaving minimal foreign material at the closure site. Moreover, the procedure is intended to be simple, fast, and requiring less pre-procedure planning, making it more accessible for both patients and healthcare professionals. Founded in 2015, Append Medical operates in the Biotechnology and Health Care industries. Recently, the company secured a significant $4.35M Series A investment on 06 July 2023, with Alive Israel HealthTech Fund and Shoni Health Ventures as the key investors. This injection of capital not only highlights investor confidence in the company but also provides the necessary resources for further development and market penetration. With its focus on addressing a critical medical need with a novel approach, Append Medical presents an intriguing opportunity for investors seeking exposure to the burgeoning field of medical technology and biotechnology.

Funding Stage	Amount	Investors	Lead Investors	Date
Series A	$4.35M	2	Alive Israel HealthTech Fund, Shoni Health Ventures	06 Jul 2023
Series A	$7.40M	3	Intellectual Ventures, Boston Scientific +1	04 Aug 2021

Funding Stage

Amount

Investors

Lead Investors

Date

Series A

$4.35M

Alive Israel HealthTech Fund, Shoni Health Ventures

06 Jul 2023

Series A

$7.40M

Intellectual Ventures, Boston Scientific +1

04 Aug 2021

FAQ About Append Medical

Append Medical develops the next generation transcatheter Left Atrial Appendage (LAA) elimination system

Append Medical was founded in 2017.

Append Medical is headquartered in Israel.

Append Medical operates in Biotechnology, Digital Health, Health Care and Medical Devices. Its work centres on Cardiology, Stroke Prevention, Transcatheter and Left Atrial Appendage (LAA).

Append Medical has approximately 22 employees.

Append Medical has completed 2 funding rounds, raising a total of $11.75M. The latest funding stage is Series A.

Top alternatives and competitors to Append Medical include Conformal Medical, Protembis GmbH, AuriGen Medical, Volta Medical, Hanyu Medical. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

Append Medical and Conformal Medical are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

General Information

Discover More

About Append Medical

Funding Rounds & Investors (2)

Append Medical Alternatives & Competitors

FAQ About Append Medical